WO2023216938A1 - Random probe, preparation method therefor and use thereof - Google Patents

Random probe, preparation method therefor and use thereof Download PDF

Info

Publication number
WO2023216938A1
WO2023216938A1 PCT/CN2023/091732 CN2023091732W WO2023216938A1 WO 2023216938 A1 WO2023216938 A1 WO 2023216938A1 CN 2023091732 W CN2023091732 W CN 2023091732W WO 2023216938 A1 WO2023216938 A1 WO 2023216938A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
dutp
amplification
transposase
random
Prior art date
Application number
PCT/CN2023/091732
Other languages
French (fr)
Chinese (zh)
Inventor
黄萌
叶莘
Original Assignee
珠海圣美生物诊断技术有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 珠海圣美生物诊断技术有限公司 filed Critical 珠海圣美生物诊断技术有限公司
Publication of WO2023216938A1 publication Critical patent/WO2023216938A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present disclosure relates to the technical field of molecular biology, and in particular to random probes, preparation methods and applications.
  • the common method for preparing fluorescent in situ hybridization probes is to obtain the target fragment through gene amplification or sequence synthesis, and then use the nick translation method to insert fluorescently labeled nucleotides, or use fluorescently labeled primers to amplify the target fragment.
  • the nick translation method requires a large starting amount of DNA ( ⁇ g level), has low efficiency of inserting fluorescently labeled nucleotides, and low probe yield, making it unsuitable for large-scale production.
  • the probe obtained by using fluorescently labeled primers for amplification is only labeled with a fluorescent signal molecule at the end, and the fluorescence intensity is low. It is necessary to design primers according to different templates and target fragment sizes.
  • the purpose of this disclosure is to provide a method for preparing random probes using transposase for target sequences. This method can obtain a large number of random probes of different sequences in one step, significantly improving the probe production efficiency. At the same time, the disclosure is random The introduction of dUTP into the entire sequence range of the probe introduces more labeling sites for subsequent probe detection, thereby reducing the detection limit and improving detection sensitivity and accuracy.
  • the second purpose of the present disclosure is to provide the application of random probes obtained based on the above preparation method in hybridization assays.
  • the present disclosure provides a method for preparing random probes, using transposase to randomly fragment the target sequence, and at the same time adding transposase recognition sequences at both ends of the obtained random target fragments, and then using the random target fragments as amplification templates to target change
  • the sequence of the locus enzyme recognition sequence is an amplification primer, which is amplified in an amplification system with a ratio of dUTP to dTTP+dUTP of 50% to 100% to obtain a random probe targeting the target sequence.
  • the transposase is selected from Tn1, Tn2, Tn3, Tn4, Tn5, Tn6, Tn7, Tn9, Tn10, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2, Tol2, MuA, Himar1 or HARBI1, so
  • the transposase recognition sequence includes the ME sequence of the transposase.
  • the transposase is Tn5
  • the ME sequence of the transposase Tn5 is 5'-AGATGTGTATAAGAGACAG-3'.
  • the DNA polymerase used for amplification is selected from Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, TLI DNA polymerase, Tne DNA polymerase, Tma DNA polymerase, vent TM DNA polymerase, Phusion One or more of TM DNA polymerase, Pfu DNA polymerase and KOD DNA polymerase.
  • the dUTP in the random probe is also labeled;
  • the labeling method includes: labeling dUTP and then adding it to the amplification system, and labeling the dUTP in the random probe as the amplification reaction proceeds; or, amplifying During the amplification reaction or after the amplification is completed, the dUTP in the obtained random probe is labeled.
  • the label is a fluorescent group label; the fluorescent group is selected from fluorescein dyes, rhodamine dyes or cyanine dyes.
  • the labeling method of dUTP includes directly coupling dUTP with the active group of the fluorescent group, or connecting dUTP and the active group of the fluorescent group through a modifying group;
  • the modified group includes a first modifying group. group or a second modifying group;
  • the first modifying group is an amino group, and the first active group connected to the first modifying group includes isothiocyanate, active ester, active carboxylic acid or sulfonyl chloride;
  • the second modification group is biotin, and the fluorescent group connected to the second modification group includes a streptavidin-modified dye, or a horseradish peroxidase-streptavidin conjugate.
  • a gap sequence reaction step is further included; or, in the amplification reaction step after the target sequence is fragmented, a gap sequence completion step is first performed. Extend the program, and then adjust the parameters for amplification.
  • the transposase recognition sequence includes the ME sequence of the transposase and a linker sequence connected to the 5' end of the ME sequence of the transposase; the number of bases A in the linker sequence is 1 to 20; Linker sequences include TCGTCGGCAGCGTC, ACGATGTCAGCGAC, or AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC.
  • the present disclosure also provides random probes prepared by using the preparation method described in the aforementioned embodiments.
  • the length of the random probe is 100-500 bps, and the number of labels per 100 nucleotides in the random probe is 3-10.
  • the present disclosure also provides the use of the random probes described in any of the aforementioned embodiments in nucleic acid hybridization assays.
  • the present disclosure provides a method for preparing random probes, which uses transposase to randomly fragment target sequences.
  • transposase recognition sequences are added to both ends of the obtained random target fragments, and then The obtained random target fragment is used as the amplification template, and the sequence targeting the transposase recognition sequence is used as the amplification primer, and amplification is carried out in an amplification system with a ratio of dUTP to (dTTP+dUTP) of 50% to 100%.
  • Random probes targeting the target sequence are obtained.
  • the probe sequences prepared by this method are random fragments derived from the target sequence, and can be used for the detection of the target sequence. Since the preparation process does not limit the specific sequence, the production efficiency is significantly improved.
  • the conventional T bases in the entire sequence of the obtained random probe will be partially replaced by U bases, and the sites substituted by U can Used as a labeling site, therefore, the random probe obtained by the preparation method provided by the present disclosure can achieve labeling within the entire sequence range, and can show more excellent sensitivity and accuracy when used for detection.
  • Figure 1 shows the results of the impact of different polymerases on dUTP compatibility and amplification efficiency obtained in Experimental Example 4 of the disclosure.
  • Figure 2 shows the FISH hybridization signal results obtained in Experimental Example 4 under different ratios of dUTP.
  • Figure 3 shows the FISH hybridization signal results after labeling with different dUTP fluorescent labeling groups in Experimental Example 5.
  • the present disclosure provides a method for preparing random probes, using transposase to randomly fragment the target sequence, while adding transposase recognition sequences at both ends of the obtained random target fragments, and then using the random target fragments As an amplification template, use the sequence targeting the transposase recognition sequence as the amplification primer, and perform amplification in an amplification system with a ratio of dUTP to dTTP+dUTP of 50% to 100% to obtain a random sequence of the target sequence. probe.
  • the "number ratio of dUTP to dTTP+dUTP" refers to the ratio of the amount of guanosine triphosphate to the sum of the amounts of "guanosine triphosphate and thymidine triphosphate".
  • the transposase is selected from Tn1, Tn2, Tn3, Tn4, Tn5, Tn6, Tn7, Tn9, Tn10, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2, Tol2, MuA, Himar1 Or HARBI1, the transposase recognition sequence includes the ME sequence of the transposase.
  • the transposase is Tn5, and the ME sequence of the transposase Tn5 is 5'-AGATGTGTATAAGAGACAG-3' (SEQ ID No. 1).
  • the DNA polymerase used for amplification is selected from the group consisting of dUTP-compatible DNA polymerase, Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, TLI DNA polymerase, and Tne DNA polymerase.
  • dUTP-compatible DNA polymerase can use amplification efficiency as an evaluation index, which refers to a DNA polymerase that maintains an amplification efficiency of more than 50% when 50% of dTTP is replaced by dUTP.
  • the dUTP in the random probe is also labeled; the labeling method includes: labeling dUTP and then adding it to the amplification system, and labeling the dUTP in the random probe as the amplification reaction proceeds. ; Alternatively, during the amplification reaction or after the amplification is completed, the dUTP in the obtained random probe is labeled.
  • the label is a fluorescent group label; the fluorescent group is selected from fluorescein dyes, rhodamine dyes, cyanine dyes or other fluorescent dyes with similar fluorescence intensity and anti-quenching ability. .
  • the fluorescein dyes include standard fluorescein and its derivatives, such as fluorescein isothiocyanate (FITC), hydroxyfluorescein (FAM), tetrachlorofluorescein (TET), etc.
  • FITC fluorescein isothiocyanate
  • FAM hydroxyfluorescein
  • TET tetrachlorofluorescein
  • the rhodamine dye materials include R101, tetraethyl rhodamine (RB200), carboxytetramethyl rhodamine (TAMRA), etc.
  • the cyanine dyes include Class I cyanine dyes: thiazole orange (TO), oxazole orange (YO) series and their dimer dyes, and Class II cyanine dyes: polymethine series cyanine dyes.
  • the present disclosure uses fluorescent dyes as labeling groups, which mainly relies on the fluorescence intensity and anti-fade ability of the fluorescent dye to meet actual detection needs. Therefore, any two indicators of fluorescence intensity and anti-fade ability are consistent with the above-mentioned Compared with the three series of dyes, no less than 50% of fluorescent dyes can be used in this disclosure as a labeling group, and should not be understood to be limited to the above three types of dyes.
  • the labeling method of dUTP includes directly coupling dUTP with the active group of the fluorescent group, or connecting dUTP and the active group of the fluorescent group through a modifying group;
  • the modified group includes The first modifying group or the second modifying group;
  • the first modifying group is an amino group, and the first active group connected to the first modifying group includes isothiocyanate, active ester, active carboxylic acid or sulfonate acid chloride;
  • the second modification group is biotin, and the fluorescent group connected to the second modification group includes a streptavidin-modified dye, or horseradish peroxidase-streptavidin coupling Connected things.
  • HRP-streptavidin conjugate or HRP direct labeling the Power Styramide TM signal amplification (PSA) or tyramide signal amplification (TSA) system based on the peroxidase principle can also be used downstream.
  • PSA Power Styramide TM signal amplification
  • TSA tyramide signal amplification
  • the label is phosphatase
  • a signal amplification system based on the principle of phosphatase can be used.
  • those skilled in the art make routine choices based on the present disclosure, which should be regarded as the labeling method using HRP-streptavidin conjugate or HRP direct labeling as described in the present disclosure.
  • a gap sequence reaction step is further included; or, in the amplification reaction step after the target sequence is fragmented, a gap sequence completion step is first performed.
  • the sequence is the extension procedure for the purpose, and then the parameters are adjusted for amplification.
  • the present disclosure also provides a step of completing the gap sequence, and this step can be performed separately or integrated into the amplification step, and is achieved by adding a pre-extension step.
  • the "reaction step of completing the gap sequence” and the “extension procedure for the purpose of completing the gap sequence” are both aimed at completing the sequence gap.
  • Specific extension parameters can be selected routinely by those skilled in the art, for example, performing amplification in an amplification system. Before the reaction, first extend at 72°C for 3 to 5 minutes to complete the gap.
  • the present disclosure can amplify target sequence fragments with a content of less than 50 ng to obtain a target sequence fragment content of 2 to 3 ⁇ g/50 ⁇ L.
  • target sequence fragments with a content of 0.01 to 0.1 ⁇ g can be used to obtain a target sequence fragment content of 4 to 6 ⁇ g/50 ⁇ L, which is significantly better than Amplification effect of probes in the prior art.
  • the transposase recognition sequence includes the ME sequence of the transposase and a linker sequence connected to the 5' end of the ME sequence of the transposase; the number of bases A in the linker sequence is 1 to 20;
  • the linker sequence includes TCGTCGGCAGCGTC (SEQ ID No. 5), ACGATGTCAGCGAC (SEQ ID No. 6), or AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC (SEQ ID No. 7).
  • the present disclosure provides random probes prepared using the preparation method described in the aforementioned embodiments.
  • the length of the random probe is 100-500 nts, and the number of labels per 100 nucleotides in the random probe is 3-10.
  • the present disclosure provides the use of the random probes described in any of the aforementioned embodiments in nucleic acid hybridization assays.
  • nucleic acid hybridization assay means that the corresponding assay method relies on the principle of complementary base pairing of nucleic acids. Since the transposase provided by the present disclosure does not specifically select the target sequence, it can use the fragmentation method provided by the present disclosure to fragment a large number of target sequences and prepare corresponding probes. Therefore, the transposase provided by the present disclosure does not specifically select the target sequence. Nucleic acid hybridization assays include but are not limited to "fluorescence in situ hybridization, nucleic acid capture, immunocytochemistry, flow cytometry or nanoflow cytometry and signal amplification" and many other assay methods based on nucleic acid hybridization.
  • target sequences applicable to this disclosure also include all nucleotide sequences obtained through amplification, extraction or synthesis, including but not limited to BAC libraries and PAC libraries. Based on the fragmentation principle of transposase, the form of the target sequence is also suitable for a variety of forms including DNA sequences, RNA sequences and DNA-RNA mixed sequences.
  • the present disclosure selects target sequences derived from the BAC library (Bacterial Artificial Chromosome, bacterial artificial chromosome library), and obtains a large number of target sequences as templates through the steps of bacterial culture and plasmid extraction, so The size of the plasmid is about 150kb ⁇ 200kb.
  • BAC library Bacterial Artificial Chromosome, bacterial artificial chromosome library
  • the target sequence obtained above is then randomly fragmented by Tn5 transposase, and transposase recognition sequences are added to both ends of the sequence.
  • This transposase recognition sequence can be used as a universal primer for subsequent amplification, and the target sequence fragmentation product has the main peak.
  • the BAC DNA fragmentation effect of different sequences and lengths is good and uniform.
  • the use of universal primers for amplification has no preference for sequences, and can be used to amplify 2 to 3 ⁇ g DNA/50 ⁇ L from a starting amount of DNA containing less than 50 ng.
  • the transposase recognition sequence can also include a linker sequence.
  • the linker sequence the content of base A is adjusted to adjust the insertion of dUTP bases in the amplification step. The quantity does not affect the efficiency of Tn5 transposase and amplification efficiency.
  • amplification reaction can amplify the 10ng template to 4-6 ⁇ g/ 50 ⁇ L.
  • the present disclosure labels random probes by fluorescein reacting with a dUTP modification group.
  • the reaction may be a reaction between an amino group and an active group, or a reaction between biotin and streptavidin. , or signal amplification through TSA, etc.
  • This reaction can also adjust the insertion efficiency by adjusting the ratio of dUTP, thereby affecting the efficiency of probe labeling.
  • 3 to 10 dye molecules/100 bases can be inserted through this method, depending on the dyes may vary.
  • the purpose of adding the linker sequence in this disclosure is to adjust the base A content of the target sequence according to the difference.
  • the content of base A in the linker sequence is designed to adjust the content of base U in the random probe, thereby improving the comprehensive detection effect including labeling degree, detection sensitivity and accuracy.
  • This embodiment provides a method for preparing a random probe targeting BAC strains, including the following steps:
  • ME-B 5'-phos-CTGTCTCTTATACACATCT-NH 2 -3' (SEQ ID No. 8)
  • a sequence that can be complementary to the ME sequence is used as a universal primer (the universal primer can be complementary to the entire sequence of the ME sequence or partially complementary to it) to perform PCR amplification.
  • the universal primer can be complementary to the entire sequence of the ME sequence or partially complementary to it.
  • dTTP was replaced with modified dUTP for multiple sets of experiments.
  • dUTP was randomly inserted into the nucleic acid sequence. The number ratios of dUTP to dTTP+dUTP were 50%, 67%, 75%, 80% and 100%.
  • the PCR product is purified and the nucleic acid concentration is measured using an ultramicrovolume spectrophotometer. Take 10ng of the product as a template for the next round of amplification and modification.
  • the reaction system is as follows:
  • Example 1 The only difference between this set of examples and Example 1 is that the complementary sequence used in the transposome constructed in this set of examples also contains a linker sequence, and the corresponding amplification primer is different from that of Example 1, and the sequence is as follows:
  • a nucleotide fragment is also connected to the 5' end of the ME sequence. You can add a nucleotide fragment to the 5' end of the A chain sequence as needed, and randomly insert base A into the nucleotide fragment to avoid repeated sequences and internal complementary sequences. Formation, adding sequences does not affect the transposase recognition and adapter insertion effects.
  • the dUTP added to the amplification system in Examples 1 to 4 was fluorescently labeled based on amino modification.
  • the method is as follows:
  • nucleic acid molecules inserted into the amino-labeled dUTP react with iFlour 488-NHS dye in a sodium bicarbonate solution with a pH of 8.3 to 8.5 at room temperature (20 to 25°C) for 2 hours, where the nucleic acid molecule concentration is 0.1 to 0.5 ⁇ g/ ⁇ L.
  • iFlour 488-NHS dye concentration is 4 ⁇ g/ ⁇ L.
  • the dUTP added to the amplification system in Examples 1 to 4 was fluorescently labeled based on biotin modification.
  • the method is as follows:
  • the nucleic acid molecule inserted into the biotin-labeled dUTP is coupled with streptavidin-iFluor488 in 1 ⁇ PBS with a neutral pH, and the reaction is carried out at room temperature or 4°C for more than 0.5 hours, and the dye concentration is 20 ⁇ g/mL.
  • the present disclosure provides the calculation method of labeling degree and probe concentration as follows:
  • the random probe After labeling, the random probe is purified, and the absorbance of the DNA fragment labeled by the random probe is measured at 260 nm and the maximum excitation wavelength of the dye.
  • the labeling degree can be calculated by calculating the ratio of the fluorescent group to the bases in the fragment (dye/base) To estimate, calculate the probe concentration.
  • Optical density measurement Measure the absorbance (Adye) of DNA fragments labeled with random probes at 260nm (A260) and maximum excitation wavelength ( ⁇ exc); to obtain accurate absorbance measurements of nucleic acids, the absorbance value of the dye at 260nm must be corrected .
  • Abase A260-(Adye ⁇ CF260).
  • CF260 is Correction Factor at 260nm (A260 correction coefficient);
  • the labeling degree can reflect the labeling efficiency of the dye molecules. Due to chemical properties and molecular size differences of different fluorescent dyes, the labeling degree may be different and cannot be compared with each other.
  • Fluorescence in situ hybridization Fix cells with Carnoy's fixative at room temperature for 30 minutes, soak in 2 ⁇ SSC at 73°C for 2 minutes, then digest with pepsin solution containing 0.5 mg/mL at 37°C for 10 minutes, wash with PBS and fix with 1% paraformaldehyde. , repeat again, gradient ethanol dehydration and drying. Drop 3 microliters of the probe solution (2.5ng/ ⁇ L) on the cell area, cover it with a coverslip, seal around the coverslip with mounting glue, and set up a hybridizer for hybridization (denaturation at 77°C for 3 minutes, hybridization at 37°C overnight) .
  • Example 2 provides three sets of random probe preparation methods. Compared with Example 1, the difference is only that the transposase used is different, the corresponding ME sequence is different and the primers are different, as shown in the following table:
  • the transposase can also be Tn1, Tn2, Tn3, Tn4, Tn6, Tn9, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2, Tol2, Himar1 or HARBI1.
  • the applicable ME sequences are all easily accessible to those skilled in the art. The obtained sequences are not exhaustive here.
  • transposase Tn5 is replaced with transposase Tn7
  • the corresponding ME sequence is replaced with the ME sequence of transposase Tn7 shown in Example 13
  • the amplification primer is replaced with Amplification primers corresponding to transposase Tn7.
  • transposase Tn5 is replaced with transposase Tn10
  • the corresponding ME sequence is replaced with the ME sequence of transposase Tn10 shown in Example 13
  • the amplification primer is replaced with Amplification primers corresponding to transposase Tn10.
  • transposase Tn5 is replaced by transposase Tn10
  • the corresponding ME sequence is replaced by the ME sequence of transposase MuA shown in Example 13
  • the amplification primer is replaced with Amplification primers corresponding to transposase MuA.
  • This embodiment provides multiple sets of examples. Compared with Example 8, the only difference is that the selected fluorescent groups are as follows.
  • Example 8 provides multiple sets of examples. Compared with Example 8, the only difference is that the DNA polymerase selected is as follows.
  • reaction system The reaction system and reaction procedure are as follows:
  • the 3'-labeled primer cannot amplify effectively because it is modified by -OH. Although the 5'-FAM-labeled primer has a higher amplification efficiency, the labeling degree is significantly lower than that after random insertion of dUTP.
  • Hybridization effect diagram (microscope scanning uses the same light source intensity, Set&Run scanning mode can set fixed exposure parameters, and Auto mode automatically adjusts exposure parameters according to the sample).
  • the fluorescence signal intensity of the 5’-FAM-labeled probe was significantly lower than that of the probe labeled after random insertion of dUTP.
  • the signal is still weak after enhanced exposure, and some cell signals are invisible to the naked eye.
  • This experimental example examines the impact of different polymerases on dUTP compatibility and amplification efficiency.
  • Using dUTP to partially or completely replace dTTP in the reaction system of Example 8 will reduce the polymerase amplification efficiency.
  • Different polymerases have different compatibility with dUTP. This leads to differences in amplification yields, so the amplification efficiency of different DNA polymerases at different dUTP contents was examined.
  • the ratios of dUTP: (dUTP+dTTP) were 0%, 50%, 80% and 100% respectively.
  • the polymerase information used is as follows:
  • the DNA polymerase is Robustart Taq
  • the dUTP replacement ratio is 50%, 67%, 80%, and 100%, respectively.
  • the labeling degree is positively related to the proportion of dUTP.
  • An increase in the dUTP proportion can improve the insertion efficiency and increase the labeling degree.
  • the FISH hybridization signal results are shown in Figure 2. It can be seen that under the same microscope light source intensity and scanning exposure parameters, the hybridization signal intensity is the same as dUTP The ratio is positively correlated. Increasing the proportion of dUTP can improve the labeling degree of the probe. Increasing the labeling degree can increase the fluorescence intensity of the probe and enhance the hybridization signal. The signal intensity of the dUTP substitution ratio is significantly higher than that of 67% and 80%, and the substitution ratio of 100% and 100% is significantly higher than that of 50%. The difference is not significant compared with 80%, which may be due to the fact that the efficiency of downstream dye labeling has reached saturation.
  • the detection results are as follows:
  • the probe directly labeled with iFluor 488-dUTP has a higher degree of labeling and the strongest hybridization signal. Due to the large molecular weight of streptavidin, steric hindrance affects the labeling efficiency of the dye, making the use of biotin Fluorescent labels linked to streptavidin have a lower degree of labeling.
  • the FISH hybridization signal results are shown in Figure 3.
  • the signal directly labeled with iFluor-488-dUTP is the strongest.
  • the biotin molecule is too large, which prevents the probe from effectively entering the nucleus and binding to the target sequence, making it difficult to use
  • the probe labeled with biotin and streptavidin cannot hybridize effectively with the target (the signal point is outside the nucleus, as shown by the arrow in Figure 3), indicating that biotin is not suitable for FISH hybridization of cells, but it does not rule out that it can be used for non-cells. of in situ hybridization.

Abstract

The present disclosure relates to the technical field of molecular biology, and in particular to a random probe, a preparation method therefor and use thereof. The present disclosure provides a random probe, a preparation method therefor and use thereof. The preparation method comprises: using a transposase to perform random fragmentation on a target sequence; in the fragmentation process, adding transposase recognition sequences at both ends of a random target fragment obtained; then taking the obtained random target fragment as an amplification template and taking a sequence targeting the transposase recognition sequences as an amplification primer, and performing amplification in an amplification system with a quantity ratio of dUTP to dTTP+dUTP of 50%-100% to obtain the random probe targeting the target sequence. The random probe prepared by the method uniformly comprises bases U capable of serving as labeling sites.

Description

随机探针、制备方法及应用Random probes, preparation methods and applications
相关申请的交叉引用Cross-references to related applications
本公开要求于2022年05月09日提交中国专利局的申请号为CN202210495738.4、名称为“随机探针、制备方法及应用”以及于2022年05月16日提交中国专利局的申请号为CN202210531129.X、名称为“随机探针、制备方法及应用”的中国专利申请的优先权,其全部内容通过引用结合在本公开中。This disclosure requires that the application number submitted to the China Patent Office on May 9, 2022 is CN202210495738.4, titled "Random Probe, Preparation Method and Application" and the application number submitted to the China Patent Office on May 16, 2022 is CN202210531129.
技术领域Technical field
本公开涉及分子生物学技术领域,尤其是涉及随机探针、制备方法及应用。The present disclosure relates to the technical field of molecular biology, and in particular to random probes, preparation methods and applications.
背景技术Background technique
荧光原位杂交探针制备常用的方法为,通过基因扩增或序列合成的方法获取目的片段,然后用缺口平移的方法插入荧光标记的核苷酸,或使用荧光标记的引物扩增目的片段。缺口平移的方法需要的DNA起始量较大(μg级),且插入荧光标记的核苷酸效率较低,探针产量低,不适合进行大规模生产。并且使用荧光标记的引物进行扩增所获得的探针仅在末端标记有荧光信号分子,荧光强度较低,需要针对不同的模板及目的片段大小设计引物。The common method for preparing fluorescent in situ hybridization probes is to obtain the target fragment through gene amplification or sequence synthesis, and then use the nick translation method to insert fluorescently labeled nucleotides, or use fluorescently labeled primers to amplify the target fragment. The nick translation method requires a large starting amount of DNA (μg level), has low efficiency of inserting fluorescently labeled nucleotides, and low probe yield, making it unsuitable for large-scale production. Moreover, the probe obtained by using fluorescently labeled primers for amplification is only labeled with a fluorescent signal molecule at the end, and the fluorescence intensity is low. It is necessary to design primers according to different templates and target fragment sizes.
发明内容Contents of the invention
本公开的目的在于,提供一种针对靶标序列利用转座酶制备随机探针的方法,该方法能够一步得到大量不同序列的随机探针,显著提高了探针生产效率,同时,本公开在随机探针的全序列范围内中引入dUTP,为后续探针检测引入更多标记位点,从而降低检测限,提高检测灵敏度和准确度。The purpose of this disclosure is to provide a method for preparing random probes using transposase for target sequences. This method can obtain a large number of random probes of different sequences in one step, significantly improving the probe production efficiency. At the same time, the disclosure is random The introduction of dUTP into the entire sequence range of the probe introduces more labeling sites for subsequent probe detection, thereby reducing the detection limit and improving detection sensitivity and accuracy.
本公开第二个目的在于,提供基于上述制备方法得到的随机探针在杂交测定中的应用。The second purpose of the present disclosure is to provide the application of random probes obtained based on the above preparation method in hybridization assays.
为了解决上述技术问题,实现上述目的,本公开提供以下技术方案:In order to solve the above technical problems and achieve the above objectives, the present disclosure provides the following technical solutions:
本公开提供随机探针的制备方法,使用转座酶对靶标序列随机片段化,同时在得到的随机靶标片段两端添加转座酶识别序列,而后以随机靶标片段为扩增模板,以靶向转 座酶识别序列的序列为扩增引物,在dUTP与dTTP+dUTP数量比为50%~100%的扩增体系中进行扩增,得到靶向靶标序列的随机探针。The present disclosure provides a method for preparing random probes, using transposase to randomly fragment the target sequence, and at the same time adding transposase recognition sequences at both ends of the obtained random target fragments, and then using the random target fragments as amplification templates to target change The sequence of the locus enzyme recognition sequence is an amplification primer, which is amplified in an amplification system with a ratio of dUTP to dTTP+dUTP of 50% to 100% to obtain a random probe targeting the target sequence.
可选地,所述转座酶选自Tn1、Tn2、Tn3、Tn4、Tn5、Tn6、Tn7、Tn9、Tn10、Tn551、Tn971、Tn916、Tn1545、Tn1681、Tgf2、Tol2、MuA、Himar1或HARBI1,所述转座酶识别序列包括转座酶的ME序列。Alternatively, the transposase is selected from Tn1, Tn2, Tn3, Tn4, Tn5, Tn6, Tn7, Tn9, Tn10, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2, Tol2, MuA, Himar1 or HARBI1, so The transposase recognition sequence includes the ME sequence of the transposase.
可选地,所述转座酶为Tn5,所述转座酶Tn5的ME序列为5’-AGATGTGTATAAGAGACAG-3’。Alternatively, the transposase is Tn5, and the ME sequence of the transposase Tn5 is 5'-AGATGTGTATAAGAGACAG-3'.
可选地,扩增使用的DNA聚合酶选自Taq DNA聚合酶,Tth DNA聚合酶,Tfl DNA聚合酶、TLI DNA聚合酶、Tne DNA聚合酶、Tma DNA聚合酶、ventTMDNA聚合酶、PhusionTMDNA聚合酶、Pfu DNA聚合酶和KOD DNA聚合酶中的一种或多种。Optionally, the DNA polymerase used for amplification is selected from Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, TLI DNA polymerase, Tne DNA polymerase, Tma DNA polymerase, vent TM DNA polymerase, Phusion One or more of TM DNA polymerase, Pfu DNA polymerase and KOD DNA polymerase.
可选地,所述随机探针中的dUTP还带有标记;标记方法包括:将dUTP标记后再加入扩增体系中,随扩增反应进行实现对随机探针中dUTP的标记;或者,扩增反应过程中或扩增完成后,对得到的随机探针中的dUTP进行标记。Optionally, the dUTP in the random probe is also labeled; the labeling method includes: labeling dUTP and then adding it to the amplification system, and labeling the dUTP in the random probe as the amplification reaction proceeds; or, amplifying During the amplification reaction or after the amplification is completed, the dUTP in the obtained random probe is labeled.
可选地,所述标记为荧光基团标记;所述荧光基团选自荧光素类染料、罗丹明类染料或菁染料。Optionally, the label is a fluorescent group label; the fluorescent group is selected from fluorescein dyes, rhodamine dyes or cyanine dyes.
可选地,dUTP的标记方法包括,dUTP与荧光基团的活性基团直接偶联,或者,通过修饰基团连接dUTP和荧光基团的活性基团;所述修饰基团包括第一修饰基团或第二修饰基团;所述第一修饰基团为氨基,与第一修饰基团连接的第一活性基团包括异硫氰酸酯、活性酯、活性羧酸或磺酰氯化物;所述第二修饰基团为生物素,与第二修饰基团连接的荧光基团包括链霉亲和素修饰的染料,或者,辣根过氧化物酶-链霉亲和素偶联物。Alternatively, the labeling method of dUTP includes directly coupling dUTP with the active group of the fluorescent group, or connecting dUTP and the active group of the fluorescent group through a modifying group; the modified group includes a first modifying group. group or a second modifying group; the first modifying group is an amino group, and the first active group connected to the first modifying group includes isothiocyanate, active ester, active carboxylic acid or sulfonyl chloride; the The second modification group is biotin, and the fluorescent group connected to the second modification group includes a streptavidin-modified dye, or a horseradish peroxidase-streptavidin conjugate.
可选地,在靶标序列片段化之后,扩增反应之前,还包括补全缺口序列反应步骤;或者,在靶标序列片段化之后的扩增反应步骤中,首先经过以补全缺口序列为目的的延伸程序,而后再调整参数进行扩增。Optionally, after the target sequence is fragmented and before the amplification reaction, a gap sequence reaction step is further included; or, in the amplification reaction step after the target sequence is fragmented, a gap sequence completion step is first performed. Extend the program, and then adjust the parameters for amplification.
可选地,所述转座酶识别序列包括转座酶的ME序列和连于转座酶的ME序列5’端的接头序列;所述接头序列中碱基A的数量为1~20;所述接头序列包括TCGTCGGCAGCGTC、ACGATGTCAGCGAC、或AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC。Optionally, the transposase recognition sequence includes the ME sequence of the transposase and a linker sequence connected to the 5' end of the ME sequence of the transposase; the number of bases A in the linker sequence is 1 to 20; Linker sequences include TCGTCGGCAGCGTC, ACGATGTCAGCGAC, or AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC.
本公开还提供采用前述实施方式所述制备方法在制备得到的随机探针。 The present disclosure also provides random probes prepared by using the preparation method described in the aforementioned embodiments.
可选地,所述随机探针的长度为100~500bps,所述随机探针中每100个核苷酸含有标记的数量为3~10个。Optionally, the length of the random probe is 100-500 bps, and the number of labels per 100 nucleotides in the random probe is 3-10.
本公开还提供了前述任一实施方式所述随机探针在核酸杂交测定中的应用。The present disclosure also provides the use of the random probes described in any of the aforementioned embodiments in nucleic acid hybridization assays.
本公开提供了一种随机探针的制备方法,该方法使用转座酶对靶标序列随机片段化,在片段化的过程中,在得到的随机靶标片段两端添加转座酶识别序列,而后以得到的随机靶标片段为扩增模板,以靶向转座酶识别序列的序列为扩增引物,在dUTP与(dTTP+dUTP)数量比为50%~100%的扩增体系中进行扩增,得到靶向靶标序列的随机探针。采用该方法制备的探针序列为来源于靶序列的随机片段,均可用于靶序列的检测。由于其制备过程并不限定具体序列,因此,生产效率得到显著提高,同时,得到的随机探针的全序列中常规的T碱基会部分地被U碱基取代,被U取代的位点能够作为标记位点使用,因此,采用本公开提供的制备方法得到的随机探针,能够实现全序列范围内的标记,用于检测时能够表现出更加优异的灵敏度和准确度。The present disclosure provides a method for preparing random probes, which uses transposase to randomly fragment target sequences. During the fragmentation process, transposase recognition sequences are added to both ends of the obtained random target fragments, and then The obtained random target fragment is used as the amplification template, and the sequence targeting the transposase recognition sequence is used as the amplification primer, and amplification is carried out in an amplification system with a ratio of dUTP to (dTTP+dUTP) of 50% to 100%. Random probes targeting the target sequence are obtained. The probe sequences prepared by this method are random fragments derived from the target sequence, and can be used for the detection of the target sequence. Since the preparation process does not limit the specific sequence, the production efficiency is significantly improved. At the same time, the conventional T bases in the entire sequence of the obtained random probe will be partially replaced by U bases, and the sites substituted by U can Used as a labeling site, therefore, the random probe obtained by the preparation method provided by the present disclosure can achieve labeling within the entire sequence range, and can show more excellent sensitivity and accuracy when used for detection.
附图说明Description of the drawings
为了更清楚地说明本公开具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本公开的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly explain the specific embodiments of the present disclosure or the technical solutions in the prior art, the drawings that need to be used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings in the following description The drawings illustrate some embodiments of the present disclosure. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without exerting creative efforts.
图1为本公开实验例4得到的不同聚合酶对dUTP兼容及扩增效率影响结果。Figure 1 shows the results of the impact of different polymerases on dUTP compatibility and amplification efficiency obtained in Experimental Example 4 of the disclosure.
图2为实验例4得到的不同比例dUTP条件下FISH杂交信号结果。Figure 2 shows the FISH hybridization signal results obtained in Experimental Example 4 under different ratios of dUTP.
图3为实验例5中不同dUTP荧光标记基团标记后,FISH杂交信号结果。Figure 3 shows the FISH hybridization signal results after labeling with different dUTP fluorescent labeling groups in Experimental Example 5.
具体实施方式Detailed ways
为使本公开实施例的目的、技术方案和优点更加清楚,下面将结合本公开实施例中的附图,对本公开实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本公开一部分实施例,而不是全部的实施例。通常在此处附图中描述和示出的本公开实施例的组件可以以各种不同的配置来布置和设计。In order to make the purpose, technical solutions and advantages of the embodiments of the present disclosure clearer, the technical solutions in the embodiments of the present disclosure will be clearly and completely described below in conjunction with the drawings in the embodiments of the present disclosure. Obviously, the described embodiments These are some embodiments of the present disclosure, but not all embodiments. The components of the embodiments of the present disclosure generally described and illustrated in the figures herein may be arranged and designed in a variety of different configurations.
因此,以下对在附图中提供的本公开的实施例的详细描述并非旨在限制要求保护的本公开的范围,而是仅仅表示本公开的选定实施例。基于本公开中的实施例,本领域普 通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本公开保护的范围。Therefore, the following detailed description of the embodiments of the disclosure provided in the appended drawings is not intended to limit the scope of the claimed disclosure, but rather to represent selected embodiments of the disclosure. Based on the embodiments in this disclosure, it is common in the art to All other embodiments obtained by those skilled in the art without creative efforts fall within the scope of protection of this disclosure.
应注意到:相似的标号和字母在下面的附图中表示类似项,因此,一旦某一项在一个附图中被定义,则在随后的附图中不需要对其进行进一步定义和解释。此外,术语“第一”或“第二”等仅用于区分描述,而不能理解为指示或暗示相对重要性。It should be noted that similar reference numerals and letters represent similar items in the following figures, therefore, once an item is defined in one figure, it does not need further definition and explanation in subsequent figures. Furthermore, terms such as “first” or “second” are only used to differentiate descriptions and are not to be construed as indicating or implying relative importance.
在可选的实施方式中,本公开提供随机探针的制备方法,使用转座酶对靶标序列随机片段化,同时在得到的随机靶标片段两端添加转座酶识别序列,而后以随机靶标片段为扩增模板,以靶向转座酶识别序列的序列为扩增引物,在dUTP与dTTP+dUTP数量比为50%~100%的扩增体系中进行扩增,得到靶向靶标序列的随机探针。In an optional embodiment, the present disclosure provides a method for preparing random probes, using transposase to randomly fragment the target sequence, while adding transposase recognition sequences at both ends of the obtained random target fragments, and then using the random target fragments As an amplification template, use the sequence targeting the transposase recognition sequence as the amplification primer, and perform amplification in an amplification system with a ratio of dUTP to dTTP+dUTP of 50% to 100% to obtain a random sequence of the target sequence. probe.
所述的“dUTP与dTTP+dUTP数量比”是指三磷酸鸟苷的数量与“三磷酸鸟苷和三磷酸胸苷”的数量之和的比例。The "number ratio of dUTP to dTTP+dUTP" refers to the ratio of the amount of guanosine triphosphate to the sum of the amounts of "guanosine triphosphate and thymidine triphosphate".
在可选的实施方式中,所述转座酶选自Tn1、Tn2、Tn3、Tn4、Tn5、Tn6、Tn7、Tn9、Tn10、Tn551、Tn971、Tn916、Tn1545、Tn1681、Tgf2、Tol2、MuA、Himar1或HARBI1,所述转座酶识别序列包括转座酶的ME序列。In alternative embodiments, the transposase is selected from Tn1, Tn2, Tn3, Tn4, Tn5, Tn6, Tn7, Tn9, Tn10, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2, Tol2, MuA, Himar1 Or HARBI1, the transposase recognition sequence includes the ME sequence of the transposase.
在可选实施方式中,所述转座酶为Tn5,所述转座酶Tn5的ME序列为5’-AGATGTGTATAAGAGACAG-3’(SEQ ID No.1)。In an optional embodiment, the transposase is Tn5, and the ME sequence of the transposase Tn5 is 5'-AGATGTGTATAAGAGACAG-3' (SEQ ID No. 1).
上述其他转座酶的ME序列部分举例如下表所示。
Examples of the ME sequence portions of other transposases mentioned above are shown in the table below.
在可选的实施方式中,扩增使用的DNA聚合酶选自兼容dUTP的DNA聚合酶,选自Taq DNA聚合酶,Tth DNA聚合酶,Tfl DNA聚合酶、TLI DNA聚合酶、Tne DNA聚合酶、Tma DNA聚合酶、ventTMDNA聚合酶、PhusionTMDNA聚合酶、Pfu DNA聚合酶和KOD DNA聚合酶中的一种或多种;优选地,选自Taq DNA聚合酶、PfuTurboCxHotstart DNA聚合酶、Robustart Taq DNA聚合酶的一种或多种,所述PfuTurboCxHotstart DNA聚合酶和Robustart Taq DNA聚合酶为上述混合聚合酶。In an alternative embodiment, the DNA polymerase used for amplification is selected from the group consisting of dUTP-compatible DNA polymerase, Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, TLI DNA polymerase, and Tne DNA polymerase. , one or more of Tma DNA polymerase, vent TM DNA polymerase, Phusion TM DNA polymerase, Pfu DNA polymerase and KOD DNA polymerase; preferably, selected from Taq DNA polymerase, PfuTurboCxHotstart DNA polymerase, One or more Robustart Taq DNA polymerases, the PfuTurboCxHotstart DNA polymerase and Robustart Taq DNA polymerase are the above-mentioned mixed polymerases.
其中,“兼容dUTP的DNA聚合酶”可用扩增效率作为评价指标,是指在50%dTTP替换为dUTP条件下,扩增效率仍保持50%以上的DNA聚合酶。Among them, "dUTP-compatible DNA polymerase" can use amplification efficiency as an evaluation index, which refers to a DNA polymerase that maintains an amplification efficiency of more than 50% when 50% of dTTP is replaced by dUTP.
在可选的实施方式中,所述随机探针中的dUTP还带有标记;标记方法包括:将dUTP标记后再加入扩增体系中,随扩增反应进行实现对随机探针中dUTP的标记;或者,扩增反应过程中或扩增完成后,对得到的随机探针中的dUTP进行标记。In an optional embodiment, the dUTP in the random probe is also labeled; the labeling method includes: labeling dUTP and then adding it to the amplification system, and labeling the dUTP in the random probe as the amplification reaction proceeds. ; Alternatively, during the amplification reaction or after the amplification is completed, the dUTP in the obtained random probe is labeled.
在可选的实施方式中,所述标记为荧光基团标记;所述荧光基团选自荧光素类染料、罗丹明类染料、菁染料或其他具有相似荧光强度和抗淬灭能力的荧光染料。In an optional embodiment, the label is a fluorescent group label; the fluorescent group is selected from fluorescein dyes, rhodamine dyes, cyanine dyes or other fluorescent dyes with similar fluorescence intensity and anti-quenching ability. .
所述荧光素类染料包括标准荧光素及其衍生物,如异硫氰酸荧光素(FITC)、羟基荧光素(FAM)、四氯荧光素(TET)等。 The fluorescein dyes include standard fluorescein and its derivatives, such as fluorescein isothiocyanate (FITC), hydroxyfluorescein (FAM), tetrachlorofluorescein (TET), etc.
所述罗丹明类染料料包括R101、四乙基罗丹明(RB200)和羧基四甲基罗丹明(TAMRA)等。The rhodamine dye materials include R101, tetraethyl rhodamine (RB200), carboxytetramethyl rhodamine (TAMRA), etc.
所述菁染料包括,Ⅰ类菁染料:噻唑橙(thiazole orange,TO)、噁唑橙(oxazole orange,YO)系列及其二聚体染料和Ⅱ类菁染料:多甲川系列菁染。The cyanine dyes include Class I cyanine dyes: thiazole orange (TO), oxazole orange (YO) series and their dimer dyes, and Class II cyanine dyes: polymethine series cyanine dyes.
应当理解的是,本公开使用荧光染料作为标记基团,主要依赖于荧光染料的荧光强度和抗淬灭能力,以满足实际检测需求,因此,凡是荧光强度和抗淬灭能力两项指标与上述三个系列染料相比,不低于50%的荧光染料均可用于本公开作为标记基团,而不应当理解为仅限定为上述三类染料。It should be understood that the present disclosure uses fluorescent dyes as labeling groups, which mainly relies on the fluorescence intensity and anti-fade ability of the fluorescent dye to meet actual detection needs. Therefore, any two indicators of fluorescence intensity and anti-fade ability are consistent with the above-mentioned Compared with the three series of dyes, no less than 50% of fluorescent dyes can be used in this disclosure as a labeling group, and should not be understood to be limited to the above three types of dyes.
在可选的实施方式中,dUTP的标记方法包括,dUTP与荧光基团的活性基团直接偶联,或者,通过修饰基团连接dUTP和荧光基团的活性基团;所述修饰基团包括第一修饰基团或第二修饰基团;所述第一修饰基团为氨基,与第一修饰基团连接的第一活性基团包括异硫氰酸酯、活性酯、活性羧酸或磺酰氯化物;所述第二修饰基团为生物素,与第二修饰基团连接的荧光基团包括链霉亲和素修饰的染料,或者,辣根过氧化物酶-链霉亲和素偶联物。In an optional embodiment, the labeling method of dUTP includes directly coupling dUTP with the active group of the fluorescent group, or connecting dUTP and the active group of the fluorescent group through a modifying group; the modified group includes The first modifying group or the second modifying group; the first modifying group is an amino group, and the first active group connected to the first modifying group includes isothiocyanate, active ester, active carboxylic acid or sulfonate acid chloride; the second modification group is biotin, and the fluorescent group connected to the second modification group includes a streptavidin-modified dye, or horseradish peroxidase-streptavidin coupling Connected things.
需要说明的是,如使用HRP-链霉亲和素偶联物或HRP直接标记,下游还可使用基于过氧化物酶原理的Power StyramideTM信号放大(PSA)或酪酰胺信号放大(TSA)系统,如标记的是磷酸酶,则可使用基于磷酸酶原理的信号放大系统。诸如此类,本领域技术人员基于本公开做出了常规选择,均应认定为本公开所述的使用HRP-链霉亲和素偶联物或HRP直接标记的标记方式。It should be noted that if HRP-streptavidin conjugate or HRP direct labeling is used, the Power Styramide TM signal amplification (PSA) or tyramide signal amplification (TSA) system based on the peroxidase principle can also be used downstream. , if the label is phosphatase, a signal amplification system based on the principle of phosphatase can be used. For example, those skilled in the art make routine choices based on the present disclosure, which should be regarded as the labeling method using HRP-streptavidin conjugate or HRP direct labeling as described in the present disclosure.
在可选的实施方式中,在靶标序列片段化之后,扩增反应之前,还包括补全缺口序列反应步骤;或者,在靶标序列片段化之后的扩增反应步骤中,首先经过以补全缺口序列为目的的延伸程序,而后再调整参数进行扩增。In an optional embodiment, after the target sequence is fragmented and before the amplification reaction, a gap sequence reaction step is further included; or, in the amplification reaction step after the target sequence is fragmented, a gap sequence completion step is first performed. The sequence is the extension procedure for the purpose, and then the parameters are adjusted for amplification.
需要说明的是,上述的“缺口序列”是指由转座酶对靶标序列片段化过程中得到的双链DNA片段中天然形成的核苷酸缺口,在保留该缺口的情况下难以实现后续的扩增步骤,因此,本公开还设置了补全缺口序列的步骤,而该步骤既可以单独实施,也可以整合入扩增步骤,通过增加前置延伸步骤来实现。“补全缺口序列反应步骤”和“以补全缺口序列为目的的延伸程序”均以补全序列缺口为目的,具体的延伸参数本领域技术人员可以进行常规选择,例如在扩增体系执行扩增反应之前,首先在72℃下延伸3~5min即可实现缺口补全。 It should be noted that the above-mentioned "gap sequence" refers to the naturally formed nucleotide gap in the double-stranded DNA fragment obtained during the fragmentation process of the target sequence by transposase. It is difficult to achieve subsequent processing while retaining this gap. Amplification step, therefore, the present disclosure also provides a step of completing the gap sequence, and this step can be performed separately or integrated into the amplification step, and is achieved by adding a pre-extension step. The "reaction step of completing the gap sequence" and the "extension procedure for the purpose of completing the gap sequence" are both aimed at completing the sequence gap. Specific extension parameters can be selected routinely by those skilled in the art, for example, performing amplification in an amplification system. Before the reaction, first extend at 72°C for 3 to 5 minutes to complete the gap.
而上述扩增反应体系,通过实验验证,本公开在补全缺口后,进行扩增能够使用含量少于50ng的靶标序列片段扩增得到靶标序列片段含量为2~3μg/50μL。在dUTP与dTTP+dUTP数量比为50%~100%的扩增体系中进行扩增,能够使用含量为0.01~0.1μg的靶标序列片段得到靶标序列片段含量为4~6μg/50μL,显著优于现有技术中探针的扩增效果。The above-mentioned amplification reaction system has been verified through experiments. After filling the gap, the present disclosure can amplify target sequence fragments with a content of less than 50 ng to obtain a target sequence fragment content of 2 to 3 μg/50 μL. When amplifying in an amplification system with a ratio of dUTP to dTTP+dUTP of 50% to 100%, target sequence fragments with a content of 0.01 to 0.1 μg can be used to obtain a target sequence fragment content of 4 to 6 μg/50 μL, which is significantly better than Amplification effect of probes in the prior art.
在可选的实施方式中,所述转座酶识别序列包括转座酶的ME序列和连于转座酶的ME序列5’端的接头序列;所述接头序列中碱基A的数量为1~20;所述接头序列包括TCGTCGGCAGCGTC(SEQ ID No.5)、ACGATGTCAGCGAC(SEQ ID No.6)、或AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC(SEQ ID No.7)。In an optional embodiment, the transposase recognition sequence includes the ME sequence of the transposase and a linker sequence connected to the 5' end of the ME sequence of the transposase; the number of bases A in the linker sequence is 1 to 20; The linker sequence includes TCGTCGGCAGCGTC (SEQ ID No. 5), ACGATGTCAGCGAC (SEQ ID No. 6), or AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC (SEQ ID No. 7).
本公开提供采用前述实施方式所述制备方法制备得到的随机探针。The present disclosure provides random probes prepared using the preparation method described in the aforementioned embodiments.
在可选的实施方式中,所述随机探针的长度为100~500nts,所述随机探针中每100个核苷酸含有标记的数量为3~10个。In an optional embodiment, the length of the random probe is 100-500 nts, and the number of labels per 100 nucleotides in the random probe is 3-10.
本公开提供了前述任一实施方式所述随机探针在核酸杂交测定中的应用。The present disclosure provides the use of the random probes described in any of the aforementioned embodiments in nucleic acid hybridization assays.
需要说明的是,“核酸杂交测定”是指,相应的测定方法依赖于核酸的碱基互补配对原则来实现。由于本公开提供的转座酶对靶标序列不存在特异选择,因此,能够利用本公开提供的片段化方法对大量的靶标序列进行片段化,并制备得到相应的探针,所以,本公开所述的核酸杂交测定包括但不限于“荧光原位杂交、核酸捕获、免疫细胞化学、流式细胞或纳米流式及其信号扩增”等众多以核酸杂交为基础的测定方法。It should be noted that "nucleic acid hybridization assay" means that the corresponding assay method relies on the principle of complementary base pairing of nucleic acids. Since the transposase provided by the present disclosure does not specifically select the target sequence, it can use the fragmentation method provided by the present disclosure to fragment a large number of target sequences and prepare corresponding probes. Therefore, the transposase provided by the present disclosure does not specifically select the target sequence. Nucleic acid hybridization assays include but are not limited to "fluorescence in situ hybridization, nucleic acid capture, immunocytochemistry, flow cytometry or nanoflow cytometry and signal amplification" and many other assay methods based on nucleic acid hybridization.
同理,本公开适用的靶标序列也包括了所有通过扩增、提取或合成的方式获取的核苷酸序列,包括但不限于BAC库和PAC库。而基于转座酶的片段化原理,靶标序列的形式也适用包括DNA序列、RNA序列以及DNA-RNA混合序列在内的多种形式。Similarly, target sequences applicable to this disclosure also include all nucleotide sequences obtained through amplification, extraction or synthesis, including but not limited to BAC libraries and PAC libraries. Based on the fragmentation principle of transposase, the form of the target sequence is also suitable for a variety of forms including DNA sequences, RNA sequences and DNA-RNA mixed sequences.
例如,在可选的实施方式中,本公开的选取来源于BAC库(Bacterial Artificial Chromosome,细菌人工染色体库)的靶标序列,通过细菌培养和质粒提取的步骤,获取大量的靶标序列作为模板,所述质粒大小约150kb~200kb。For example, in an optional embodiment, the present disclosure selects target sequences derived from the BAC library (Bacterial Artificial Chromosome, bacterial artificial chromosome library), and obtains a large number of target sequences as templates through the steps of bacterial culture and plasmid extraction, so The size of the plasmid is about 150kb~200kb.
而后通过Tn5转座酶对上述得到的靶标序列进行随机片段化,同时在序列两端添加转座酶识别序列,该转座酶识别序列可作为后续扩增的通用引物,靶标序列片段化产物主峰在300~500bps,不同序列和长度的BAC DNA片段化效果均一性好。使用通用引物扩增对序列无偏好性,可用含量少于50ngDNA起始量扩增得到2~3μg DNA/50μL。 The target sequence obtained above is then randomly fragmented by Tn5 transposase, and transposase recognition sequences are added to both ends of the sequence. This transposase recognition sequence can be used as a universal primer for subsequent amplification, and the target sequence fragmentation product has the main peak. At 300~500bps, the BAC DNA fragmentation effect of different sequences and lengths is good and uniform. The use of universal primers for amplification has no preference for sequences, and can be used to amplify 2 to 3 μg DNA/50 μL from a starting amount of DNA containing less than 50 ng.
此外,转座酶识别序列除保留影响Tn5转座酶识别和活性的ME序列外,还可以包含接头序列,在接头序列中,通过调整碱基A的含量来调整扩增步骤中插入dUTP碱基的数量,且不影响Tn5转座酶的效率及扩增效率。In addition, in addition to retaining the ME sequence that affects the recognition and activity of Tn5 transposase, the transposase recognition sequence can also include a linker sequence. In the linker sequence, the content of base A is adjusted to adjust the insertion of dUTP bases in the amplification step. The quantity does not affect the efficiency of Tn5 transposase and amplification efficiency.
在扩增时通过将PCR反应体系内部分dTTP替换为dUTP,使用可兼容dUTP的DNA聚合酶将dUTP随机插入到探针序列内,由此扩增反应可将10ng模板扩增至4~6μg/50μL。During amplification, part of the dTTP in the PCR reaction system is replaced with dUTP, and a DNA polymerase compatible with dUTP is used to randomly insert dUTP into the probe sequence. The amplification reaction can amplify the 10ng template to 4-6μg/ 50μL.
在可选的实施方式中,本公开通过与dUTP修饰基团反应的荧光素对随机探针进行标记,所述反应可以是氨基与活性基团的反应,或生物素与链霉亲和素反应,或通过TSA等进行信号放大,该反应还可通过调整dUTP的比例来调整插入效率,从而影响探针标记的效率,通过该方法一般可插入3~10个染料分子/100个碱基,不同的染料可能存在差异。In an optional embodiment, the present disclosure labels random probes by fluorescein reacting with a dUTP modification group. The reaction may be a reaction between an amino group and an active group, or a reaction between biotin and streptavidin. , or signal amplification through TSA, etc. This reaction can also adjust the insertion efficiency by adjusting the ratio of dUTP, thereby affecting the efficiency of probe labeling. Generally, 3 to 10 dye molecules/100 bases can be inserted through this method, depending on the dyes may vary.
需要说明的是,随机探针序列中碱基U含量的提高能够提高随机探针的标记度和靶标序列的检出率,但是碱基U含量的提高会使得随机探针与靶标序列的结合强度降低,从而影响检出的灵敏度和准确度,因此,需要对随机探针全序列中碱基U的含量进行调整,而本公开添加接头序列的目的,即为根据靶标序列碱基A含量的差异,在接头序列中设计性地调整碱基A的含量,来实现对随机探针中碱基U含量的调整,从而提高包括标记度、检出的灵敏度和准确度在内的综合检出效果。It should be noted that increasing the base U content in the random probe sequence can improve the labeling degree of the random probe and the detection rate of the target sequence, but the increase in the base U content will reduce the binding strength of the random probe to the target sequence. Decrease, thus affecting the sensitivity and accuracy of detection. Therefore, the content of base U in the full sequence of the random probe needs to be adjusted. The purpose of adding the linker sequence in this disclosure is to adjust the base A content of the target sequence according to the difference. , the content of base A in the linker sequence is designed to adjust the content of base U in the random probe, thereby improving the comprehensive detection effect including labeling degree, detection sensitivity and accuracy.
实施例Example
下面结合附图,对本公开的一些实施方式作详细说明。在不冲突的情况下,下述的实施例及实施例中的特征可以相互组合。Some embodiments of the present disclosure will be described in detail below with reference to the accompanying drawings. The following embodiments and features in the embodiments may be combined with each other without conflict.
实施例1Example 1
本实施例提供了一种靶向BAC菌株随机探针的制备方法,包括以下步骤:This embodiment provides a method for preparing a random probe targeting BAC strains, including the following steps:
(1)序列获取(1) Sequence acquisition
使用含氯霉素的LB培养基培养BAC菌株,按照BAC DNA纯化试剂盒或质粒纯化试剂盒(NucleoBondXtra BAC,厂家:MACHEREY-NAGEL)提取BAC DNA。Use LB medium containing chloramphenicol to cultivate BAC strains, and extract BAC DNA according to the BAC DNA purification kit or plasmid purification kit (NucleoBondXtra BAC, manufacturer: MACHEREY-NAGEL).
(2)转座体(TTE Mix)制备(2) Preparation of transposome (TTE Mix)
根据转座酶Tn5设计19bps的ME互补序列,序列如下:Design a 19bps ME complementary sequence based on transposase Tn5. The sequence is as follows:
ME-A:5’-AGATGTGTATAAGAGACAG-3’(SEQ ID No.1)ME-A:5’-AGATGTGTATAAGAGACAG-3’(SEQ ID No.1)
ME-B:5’-phos-CTGTCTCTTATACACATCT-NH2-3’(SEQ ID No.8) ME-B: 5'-phos-CTGTCTCTTATACACATCT-NH 2 -3' (SEQ ID No. 8)
将ME-A和ME-B等摩尔浓度混合并复性成双链,按转座酶(TruePrepTagment Enzyme,诺维赞)使用说明制备转座体。Mix ME-A and ME-B at equimolar concentrations and renature into double strands, and prepare the transposome according to the instructions for transposase (TruePrepTagment Enzyme, Novizan).
(3)DNA片段化及接头添加(3)DNA fragmentation and adapter addition
将BAC DNA稀释至50ng/μL,根据反应管数按下表配制反应体系,55℃反应10分钟:
Dilute BAC DNA to 50ng/μL, prepare the reaction system according to the following table according to the number of reaction tubes, and react at 55°C for 10 minutes:
反应结束后使用磁珠或柱纯化片段化产物。After the reaction, magnetic beads or columns are used to purify the fragmented products.
(4)PCR扩增(4)PCR amplification
以片段化的DNA为模板,能与ME序列互补结合的序列作为通用引物(所述通用引物可以与ME序列全序列对应互补,也可以与其部分互补),进行PCR扩增,扩增反应中将部分或全部的dTTP替换为带修饰的dUTP进行多组实验,扩增时将dUTP随机插入到核酸序列中,所述dUTP与dTTP+dUTP数量比为50%、67%、75%、80%和100%。Using the fragmented DNA as a template, a sequence that can be complementary to the ME sequence is used as a universal primer (the universal primer can be complementary to the entire sequence of the ME sequence or partially complementary to it) to perform PCR amplification. During the amplification reaction, Part or all of dTTP was replaced with modified dUTP for multiple sets of experiments. During amplification, dUTP was randomly inserted into the nucleic acid sequence. The number ratios of dUTP to dTTP+dUTP were 50%, 67%, 75%, 80% and 100%.
根据反应管数按下表配制反应体系:
Prepare the reaction system according to the following table according to the number of reaction tubes:
运行以下程序:
Run the following program:
纯化PCR产物,使用超微量分光光度计测核酸浓度。取10ng产物作为模板进行下一轮扩增及修饰,反应体系如下:
The PCR product is purified and the nucleic acid concentration is measured using an ultramicrovolume spectrophotometer. Take 10ng of the product as a template for the next round of amplification and modification. The reaction system is as follows:
运行以下程序:
Run the following program:
纯化PCR产物,得到随机探针。 Purify the PCR product to obtain random probes.
实施例2~4Examples 2 to 4
本组实施例与实施例1的区别仅在于,本组实施例构建的转座体使用的互补序列中还含有接头序列,以及对应的扩增引物与实施例1不同,序列如下:

The only difference between this set of examples and Example 1 is that the complementary sequence used in the transposome constructed in this set of examples also contains a linker sequence, and the corresponding amplification primer is different from that of Example 1, and the sequence is as follows:

本组实施例在ME序列的5’端还连有可根据需要在A链序列5’端添加核苷酸片段,将碱基A随机插入到核苷酸片段中,避免重复序列和内部互补序列形成,添加序列不影响转座酶的识别和接头插入效果。In this set of embodiments, a nucleotide fragment is also connected to the 5' end of the ME sequence. You can add a nucleotide fragment to the 5' end of the A chain sequence as needed, and randomly insert base A into the nucleotide fragment to avoid repeated sequences and internal complementary sequences. Formation, adding sequences does not affect the transposase recognition and adapter insertion effects.
实施例5~8Examples 5 to 8
本组实施例分别对实施例1~4中加入到扩增体系中的dUTP进行基于氨基修饰的荧光标记,方法如下:In this set of examples, the dUTP added to the amplification system in Examples 1 to 4 was fluorescently labeled based on amino modification. The method is as follows:
插入氨基标记dUTP的核酸分子与iFlour 488-NHS染料在pH为8.3~8.5的碳酸氢钠溶液中,于室温(20~25℃)条件下反应2h,其中核酸分子浓度为0.1~0.5μg/μL,iFlour 488-NHS染料浓度为4μg/μL。The nucleic acid molecules inserted into the amino-labeled dUTP react with iFlour 488-NHS dye in a sodium bicarbonate solution with a pH of 8.3 to 8.5 at room temperature (20 to 25°C) for 2 hours, where the nucleic acid molecule concentration is 0.1 to 0.5 μg/μL. , iFlour 488-NHS dye concentration is 4μg/μL.
实施例9~12 Examples 9 to 12
本组实施例分别对实施例1~4中加入到扩增体系中的dUTP进行基于生物素修饰的荧光标记,方法如下:In this set of examples, the dUTP added to the amplification system in Examples 1 to 4 was fluorescently labeled based on biotin modification. The method is as follows:
插入生物素标记dUTP的核酸分子与链霉亲和素偶联-iFluor488在pH为中性的1×PBS中进行,室温或4℃反应0.5h以上,染料浓度为20μg/mL。The nucleic acid molecule inserted into the biotin-labeled dUTP is coupled with streptavidin-iFluor488 in 1×PBS with a neutral pH, and the reaction is carried out at room temperature or 4°C for more than 0.5 hours, and the dye concentration is 20 μg/mL.
为了表征不同实施例获得的随机探针取得的技术效果,本公开提供了标记度及探针浓度计算方法如下:In order to characterize the technical effects achieved by the random probes obtained in different embodiments, the present disclosure provides the calculation method of labeling degree and probe concentration as follows:
对标记后对随机探针进行纯化,测量260nm和染料最大激发波长下被随机探针标记的DNA片段的吸光度,标记度可以通过计算荧光基团与片段中碱基(染料/碱基)的比例来估计,计算探针浓度。After labeling, the random probe is purified, and the absorbance of the DNA fragment labeled by the random probe is measured at 260 nm and the maximum excitation wavelength of the dye. The labeling degree can be calculated by calculating the ratio of the fluorescent group to the bases in the fragment (dye/base) To estimate, calculate the probe concentration.
光密度测量:在260nm(A260)和最大激发波长(λexc)下测量被随机探针标记的DNA片段的吸光度(Adye);要获得核酸的准确吸光度测量值,必须校正染料在260nm处的吸光值。使用下列公式校正A260读数:
Abase=A260-(Adye×CF260)。
Optical density measurement: Measure the absorbance (Adye) of DNA fragments labeled with random probes at 260nm (A260) and maximum excitation wavelength (λexc); to obtain accurate absorbance measurements of nucleic acids, the absorbance value of the dye at 260nm must be corrected . Use the following formula to correct the A260 reading:
Abase=A260-(Adye×CF260).
不同染料的参数可在厂家官网查询:The parameters of different dyes can be found on the manufacturer’s official website:
CF260为Correction Factor at 260nm(A260校正系数);CF260 is Correction Factor at 260nm (A260 correction coefficient);
εdye为Extinction coefficients of dye(染料消光系数)。εdye is Extinction coefficients of dye (dye extinction coefficient).
计算标记效率,染料/碱基计算方法如下:
dye/base=(Adye×εbase)/(Abase×εdye);
dsDNA:εbase=6600cm-1M-1
ssDNA:εbase=8900cm-1M-1
oligonucleotide:εbase=10000cm-1M-1
To calculate labeling efficiency, the dye/base calculation method is as follows:
dye/base=(Adye×εbase)/(Abase×εdye);
dsDNA:εbase=6600cm -1 M -1 ;
ssDNA:εbase=8900cm -1 M -1 ;
oligonucleotide:εbase=10000cm -1 M -1 .
例:dye/base=0.05相当于将5个染料dUTP插入含有100个核苷酸的DNA片段中,或50bp的PCR片段中。假设dATP、dCTP、dGTP和dTTP在DNA片段中的分布是相等的,相当于25个dTTP中有5个被染料-dUTP取代。Example: dye/base=0.05 is equivalent to inserting 5 dyes dUTP into a DNA fragment containing 100 nucleotides, or into a 50bp PCR fragment. Assuming that the distribution of dATP, dCTP, dGTP and dTTP in the DNA fragment is equal, it is equivalent to 5 out of 25 dTTP being replaced by dye-dUTP.
标记度可体现染料分子的标记效率,不同荧光染料化学性质和分子大小差异等原因,标记度可能存在差异,不可相互比较。The labeling degree can reflect the labeling efficiency of the dye molecules. Due to chemical properties and molecular size differences of different fluorescent dyes, the labeling degree may be different and cannot be compared with each other.
计算探针浓度,浓度计算方法如下:
探针浓度(mg/mL)=(Abase×MWbase)/(εbase×path length);
dsDNA:MWbase=330g/mol;
dsDNA:εbase=6600cm-1M-1
Calculate the probe concentration. The concentration calculation method is as follows:
Probe concentration (mg/mL)=(Abase×MWbase)/(εbase×path length);
dsDNA:MWbase=330g/mol;
dsDNA: εbase=6600cm -1 M -1 .
用乙醇沉淀法沉淀标记后的探针,用杂交缓冲液重悬探针至2.5ng/μL浓度。Use ethanol precipitation to precipitate the labeled probe, and resuspend the probe in hybridization buffer to a concentration of 2.5ng/μL.
荧光原位杂交:用卡诺氏固定液室温固定细胞30min,用2×SSC 73℃浸泡2min,随后用含有0.5mg/mL胃蛋白酶溶液37℃消化10min,PBS清洗后用1%多聚甲醛固定,重复一遍,梯度乙醇脱水晾干。将3微升探针溶液(2.5ng/μL)滴在细胞区域,盖上盖玻片,用封片胶将盖玻片四周密封,置杂交仪杂交(77℃变性3min,37℃杂交过夜)。用0.3%NP-40的0.4×SSC 70℃清洗2min,0.1%NP-40的2×SSC溶液室温清洗2min,随后用DAPI染细胞核,用荧光显微镜进行扫描及图像分析。Fluorescence in situ hybridization: Fix cells with Carnoy's fixative at room temperature for 30 minutes, soak in 2×SSC at 73°C for 2 minutes, then digest with pepsin solution containing 0.5 mg/mL at 37°C for 10 minutes, wash with PBS and fix with 1% paraformaldehyde. , repeat again, gradient ethanol dehydration and drying. Drop 3 microliters of the probe solution (2.5ng/μL) on the cell area, cover it with a coverslip, seal around the coverslip with mounting glue, and set up a hybridizer for hybridization (denaturation at 77°C for 3 minutes, hybridization at 37°C overnight) . Wash with 0.3% NP-40 in 0.4×SSC at 70°C for 2 min, and with 0.1% NP-40 in 2×SSC at room temperature for 2 min. Then, the nuclei are stained with DAPI, and scanned and image analyzed using a fluorescence microscope.
实施例13Example 13
本实施例提供了3组随机探针制备方法,与实施例1相比,区别仅在于使用的转座酶不同,对应的ME序列不同和引物不同,如下表所示:

This example provides three sets of random probe preparation methods. Compared with Example 1, the difference is only that the transposase used is different, the corresponding ME sequence is different and the primers are different, as shown in the following table:

所述转座酶还可以为Tn1、Tn2、Tn3、Tn4、Tn6、Tn9、Tn551、Tn971、Tn916、Tn1545、Tn1681、Tgf2、Tol2、Himar1或HARBI1,可应用的ME序列均为本领域技术人员容易获得的序列,在此不再穷举。The transposase can also be Tn1, Tn2, Tn3, Tn4, Tn6, Tn9, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2, Tol2, Himar1 or HARBI1. The applicable ME sequences are all easily accessible to those skilled in the art. The obtained sequences are not exhaustive here.
实施例14Example 14
本实施例与实施例2相比,区别仅在于将转座酶Tn5替换为转座酶Tn7,相应ME序列替换为实施例13所示的转座酶Tn7的ME序列,扩增引物替换为与转座酶Tn7对应的扩增引物。Compared with Example 2, the only difference between this example and Example 2 is that transposase Tn5 is replaced with transposase Tn7, the corresponding ME sequence is replaced with the ME sequence of transposase Tn7 shown in Example 13, and the amplification primer is replaced with Amplification primers corresponding to transposase Tn7.
实施例15 Example 15
本实施例与实施例2相比,区别仅在于将转座酶Tn5替换为转座酶Tn10,相应ME序列替换为实施例13所示的转座酶Tn10的ME序列,扩增引物替换为与转座酶Tn10对应的扩增引物。Compared with Example 2, the only difference between this example and Example 2 is that transposase Tn5 is replaced with transposase Tn10, the corresponding ME sequence is replaced with the ME sequence of transposase Tn10 shown in Example 13, and the amplification primer is replaced with Amplification primers corresponding to transposase Tn10.
实施例16Example 16
本实施例与实施例2相比,区别仅在于将转座酶Tn5替换为转座酶Tn10,相应ME序列替换为实施例13所示的转座酶MuA的ME序列,扩增引物替换为与转座酶MuA对应的扩增引物。Compared with Example 2, the only difference between this example and Example 2 is that transposase Tn5 is replaced by transposase Tn10, the corresponding ME sequence is replaced by the ME sequence of transposase MuA shown in Example 13, and the amplification primer is replaced with Amplification primers corresponding to transposase MuA.
实施例17Example 17
本实施例提供了多组实施例,与实施例8相比,区别仅在于选用的荧光基团如下所示。
This embodiment provides multiple sets of examples. Compared with Example 8, the only difference is that the selected fluorescent groups are as follows.
实施例18Example 18
本实施例提供了多组实施例,与实施例8相比,区别仅在于选用的DNA聚合酶如下所示。

This example provides multiple sets of examples. Compared with Example 8, the only difference is that the DNA polymerase selected is as follows.

实验例1Experimental example 1
按照以下反应体系通过缺口平移法制备靶向BAC DNA的探针,反应体系参考下表:
Prepare the probe targeting BAC DNA by the nick translation method according to the following reaction system. Refer to the table below for the reaction system:
下游荧光标记步骤与本实施例5一致。The downstream fluorescent labeling steps are consistent with Example 5.
按探针浓度2.5ng/μL,每人份探针4μL,计算生产5000人份探针需要的反应管数。
Assuming that the probe concentration is 2.5ng/μL and each probe is 4μL, calculate the number of reaction tubes required to produce 5,000 probes.
结论:本公开提供的随机探针技术方案的探针得率明显优于缺口平移法。Conclusion: The probe yield of the random probe technical solution provided by this disclosure is significantly better than that of the gap translation method.
实验例2Experimental example 2
荧光标记引物与dUTP标记效果对比。Comparison of fluorescently labeled primers and dUTP labeling effects.
方法:对比使用荧光标记的引物直接标记效果与插入dUTP后间接标记荧光素的效果。标记的荧光基团为FAM。 Method: Compare the direct labeling effect using fluorescently labeled primers and the indirect labeling effect of fluorescein after inserting dUTP. The labeled fluorophore is FAM.
引物:
Primers:
分组:
Grouping:
反应体系和反应程序如下表:

The reaction system and reaction procedure are as follows:

产量及标记度对比结果:
Comparison results of yield and labeling degree:
3’标记的引物由于-OH被修饰,无法有效扩增,5’-FAM标记引物虽然扩增效率较高,但是标记度明显低于dUTP随机插入后标记的标记度。The 3'-labeled primer cannot amplify effectively because it is modified by -OH. Although the 5'-FAM-labeled primer has a higher amplification efficiency, the labeling degree is significantly lower than that after random insertion of dUTP.
杂交效果图:(显微镜扫描使用相同光源强度,Set&Run扫描模式可设置固定曝光参数,Auto模式根据样本自动调价曝光参数)。Hybridization effect diagram: (microscope scanning uses the same light source intensity, Set&Run scanning mode can set fixed exposure parameters, and Auto mode automatically adjusts exposure parameters according to the sample).
在相同光源和曝光参数的条件下,5’-FAM标记的探针荧光信号强度明显低于dUTP随机插入后标记的探针。增强曝光后信号仍然较弱,部分细胞信号肉眼不可见。Under the same light source and exposure parameters, the fluorescence signal intensity of the 5’-FAM-labeled probe was significantly lower than that of the probe labeled after random insertion of dUTP. The signal is still weak after enhanced exposure, and some cell signals are invisible to the naked eye.
实验例3Experimental example 3
采用上述标记度的检测方法,对实施例5~8提供的4种随机探针的标记度进行检测,结果如下:

The above-mentioned detection method of labeling degree was used to detect the labeling degree of the four random probes provided in Examples 5 to 8. The results are as follows:

可以看出,在接头处增加A碱基的数量可提高探针的标记度。It can be seen that increasing the number of A bases at the linker can improve the labeling degree of the probe.
实验例4Experimental example 4
本实验例考察不同聚合酶对dUTP兼容及扩增效率影响,在实施例8的反应体系内使用dUTP部分或全部替代dTTP会使聚合酶扩增效率下降,不同聚合酶对dUTP的兼容性不同,导致扩增产量存在差异,从而考察选择不同的DNA聚合酶在不同dUTP含量下的扩增效率,dUTP:(dUTP+dTTP)的数量比例分别为0%、50%、80%和100%。This experimental example examines the impact of different polymerases on dUTP compatibility and amplification efficiency. Using dUTP to partially or completely replace dTTP in the reaction system of Example 8 will reduce the polymerase amplification efficiency. Different polymerases have different compatibility with dUTP. This leads to differences in amplification yields, so the amplification efficiency of different DNA polymerases at different dUTP contents was examined. The ratios of dUTP: (dUTP+dTTP) were 0%, 50%, 80% and 100% respectively.
使用的聚合酶信息如下:
The polymerase information used is as follows:
扩增结果如图1所示,可以看出,三种聚合酶均可兼容dUTP的反应体系,在50%~80%dUTP下单管产量在5~7μg,全部替换为dUTP后扩增效率显著下降,与另外两种聚合酶相比,全部替换条件下,Robustart Taq的扩增效率下降较低,显示出较好的兼容性。The amplification results are shown in Figure 1. It can be seen that all three polymerases are compatible with the dUTP reaction system. The output of a single tube is 5 to 7 μg under 50% to 80% dUTP. The amplification efficiency is significant after all are replaced with dUTP. Compared with the other two polymerases, under all substitution conditions, the amplification efficiency of Robustart Taq dropped lower, showing better compatibility.
按照上述检测标记的方法检测DNA聚合酶为Robustart Taq,而dUTP替换比例分别为50%、67%、80%、100%条件下的标记度,结果如下:

According to the above method of detecting labeling, the DNA polymerase is Robustart Taq, and the dUTP replacement ratio is 50%, 67%, 80%, and 100%, respectively. The results are as follows:

由上表可以看出,标记度与dUTP的比例正相关,dUTP比例升高可提高插入效率,使标记度提高。As can be seen from the table above, the labeling degree is positively related to the proportion of dUTP. An increase in the dUTP proportion can improve the insertion efficiency and increase the labeling degree.
dUTP替换比例分别为50%、67%、80%、100%条件下,FISH杂交信号结果如图2所示,可以看出,在相同显微镜光源强度和扫描曝光参数条件下,杂交信号强度与dUTP比例呈正相关。dUTP比例升高可提高探针标记度,标记度升高可使探针荧光强度增加,杂交信号增强,dUTP替换比例为67%和80%信号强度明显高于50%,替换比例为100%与80%相比差异不显著,可能是由于下游染料标记的效率已经达到饱和。When the dUTP replacement ratios are 50%, 67%, 80%, and 100% respectively, the FISH hybridization signal results are shown in Figure 2. It can be seen that under the same microscope light source intensity and scanning exposure parameters, the hybridization signal intensity is the same as dUTP The ratio is positively correlated. Increasing the proportion of dUTP can improve the labeling degree of the probe. Increasing the labeling degree can increase the fluorescence intensity of the probe and enhance the hybridization signal. The signal intensity of the dUTP substitution ratio is significantly higher than that of 67% and 80%, and the substitution ratio of 100% and 100% is significantly higher than that of 50%. The difference is not significant compared with 80%, which may be due to the fact that the efficiency of downstream dye labeling has reached saturation.
实验例5Experimental example 5
本组实验考查了在实施例8的基础上,不同dUTP荧光标记基团标记对于标记度和FISH杂交结果的影响,荧光标记基团信息如下:
This group of experiments examined the impact of different dUTP fluorescent labeling groups on the labeling degree and FISH hybridization results based on Example 8. The fluorescent labeling group information is as follows:
按照上述标记度检测方法,检测结果如下:
According to the above labeling detection method, the detection results are as follows:
由上表可以看出,iFluor 488-dUTP直接标记的探针标记度较高,且杂交信号最强,由于链霉亲和素分子量较大,空间位阻影响染料的标记效率,使得使用生物素与链霉亲和素连接标记荧光的标记度较低。As can be seen from the table above, the probe directly labeled with iFluor 488-dUTP has a higher degree of labeling and the strongest hybridization signal. Due to the large molecular weight of streptavidin, steric hindrance affects the labeling efficiency of the dye, making the use of biotin Fluorescent labels linked to streptavidin have a lower degree of labeling.
不同dUTP荧光标记基团标记后,FISH杂交信号结果如图3所示,iFluor-488-dUTP直接标记的信号最强,生物素分子过大导致探针无法有效进入细胞核与目的序列结合,使得使用生物素与链霉亲和素连接标记的探针无法与目标有效杂交(信号点在细胞核外,图3箭头所示),表明生物素不适用于细胞的FISH杂交,但不排除可用于非细胞的原位杂交。After labeling with different dUTP fluorescent labeling groups, the FISH hybridization signal results are shown in Figure 3. The signal directly labeled with iFluor-488-dUTP is the strongest. The biotin molecule is too large, which prevents the probe from effectively entering the nucleus and binding to the target sequence, making it difficult to use The probe labeled with biotin and streptavidin cannot hybridize effectively with the target (the signal point is outside the nucleus, as shown by the arrow in Figure 3), indicating that biotin is not suitable for FISH hybridization of cells, but it does not rule out that it can be used for non-cells. of in situ hybridization.
最后应说明的是:以上各实施例仅用以说明本公开的技术方案,而非对其限制;尽管参照前述各实施例对本公开进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本公开各实施例技术方案的范围。 Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present disclosure, but not to limit it; although the present disclosure has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: The technical solutions described in the foregoing embodiments can still be modified, or some or all of the technical features can be equivalently replaced; and these modifications or substitutions do not deviate from the essence of the corresponding technical solutions from the technical solutions of the embodiments of the present disclosure. scope.

Claims (12)

  1. 随机探针的制备方法,其特征在于,使用转座酶对靶标序列随机片段化,同时在得到的随机靶标片段两端添加转座酶识别序列,而后以随机靶标片段为扩增模板,以靶向转座酶识别序列的序列为扩增引物,在dUTP与dTTP+dUTP数量比为50%~100%的扩增体系中进行扩增,得到靶向靶标序列的随机探针。The method for preparing random probes is characterized by using transposase to randomly fragment the target sequence, adding transposase recognition sequences to both ends of the obtained random target fragments, and then using the random target fragments as amplification templates to target The sequence toward the transposase recognition sequence is an amplification primer, which is amplified in an amplification system with a ratio of dUTP to dTTP+dUTP of 50% to 100% to obtain a random probe targeting the target sequence.
  2. 根据权利要求1所述的制备方法,其特征在于,所述转座酶选自Tn1、Tn2、Tn3、Tn4、Tn5、Tn6、Tn7、Tn9、Tn10、Tn551、Tn971、Tn916、Tn1545、Tn1681、Tgf2、Tol2、MuA、Himar1或HARBI1,所述转座酶识别序列包括转座酶的ME序列。The preparation method according to claim 1, characterized in that the transposase is selected from Tn1, Tn2, Tn3, Tn4, Tn5, Tn6, Tn7, Tn9, Tn10, Tn551, Tn971, Tn916, Tn1545, Tn1681, Tgf2 , Tol2, MuA, Himar1 or HARBI1, the transposase recognition sequence includes the ME sequence of the transposase.
  3. 根据权利要求2所述的制备方法,其特征在于,所述转座酶为Tn5,所述转座酶Tn5的ME序列为5’-AGATGTGTATAAGAGACAG-3’。The preparation method according to claim 2, characterized in that the transposase is Tn5, and the ME sequence of the transposase Tn5 is 5’-AGATGTGTATAAGAGACAG-3’.
  4. 根据权利要求1所述的制备方法,其特征在于,扩增使用的DNA聚合酶选自Taq DNA聚合酶,Tth DNA聚合酶,Tfl DNA聚合酶、TLI DNA聚合酶、Tne DNA聚合酶、Tma DNA聚合酶、ventTMDNA聚合酶、PhusionTMDNA聚合酶、Pfu DNA聚合酶或KOD DNA聚合酶中的一种或多种。The preparation method according to claim 1, characterized in that the DNA polymerase used for amplification is selected from Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, TLI DNA polymerase, Tne DNA polymerase, Tma DNA polymerase, vent DNA polymerase, Phusion DNA polymerase, Pfu DNA polymerase or KOD DNA polymerase.
  5. 根据权利要求1~4任一项所述的制备方法,其特征在于,所述随机探针中的dUTP还带有标记;The preparation method according to any one of claims 1 to 4, wherein the dUTP in the random probe is also labeled;
    标记方法包括:Marking methods include:
    将dUTP标记后再加入扩增体系中,随扩增反应进行实现对随机探针中dUTP的标记;或者,Label dUTP and then add it to the amplification system, and label the dUTP in the random probe as the amplification reaction proceeds; or,
    扩增反应过程中或扩增完成后,对得到的随机探针中的dUTP进行标记。During the amplification reaction or after the amplification is completed, the dUTP in the obtained random probe is labeled.
  6. 根据权利要求5所述的制备方法,其特征在于,所述标记为荧光基团标记;The preparation method according to claim 5, characterized in that the label is a fluorescent group label;
    所述荧光基团选自荧光素类染料、罗丹明类染料或菁染料。The fluorescent group is selected from fluorescein dyes, rhodamine dyes or cyanine dyes.
  7. 根据权利要求6所述的制备方法,其特征在于,dUTP的标记方法包括,dUTP与荧光基团的活性基团直接偶联,或者,通过修饰基团连接dUTP和荧光基团的活性基团;The preparation method according to claim 6, characterized in that the labeling method of dUTP includes directly coupling dUTP with the active group of the fluorescent group, or connecting dUTP and the active group of the fluorescent group through a modification group;
    所述修饰基团包括第一修饰基团或第二修饰基团;The modifying group includes a first modifying group or a second modifying group;
    所述第一修饰基团为氨基,与第一修饰基团连接的第一活性基团包括异硫氰酸酯、活性酯、活性羧酸或磺酰氯化物;The first modifying group is an amino group, and the first active group connected to the first modifying group includes isothiocyanate, active ester, active carboxylic acid or sulfonyl chloride;
    所述第二修饰基团为生物素,与第二修饰基团连接的荧光基团包括链霉亲和素修饰的染料,或者,辣根过氧化物酶-链霉亲和素偶联物。 The second modification group is biotin, and the fluorescent group connected to the second modification group includes a streptavidin-modified dye, or a horseradish peroxidase-streptavidin conjugate.
  8. 根据权利要求1~4任一项所述的制备方法,其特征在于,在靶标序列片段化之后,扩增反应之前,还包括补全缺口序列反应步骤;或者,The preparation method according to any one of claims 1 to 4, characterized in that, after the target sequence is fragmented and before the amplification reaction, a gap sequence completion reaction step is further included; or,
    在靶标序列片段化之后的扩增反应步骤中,首先经过以补全缺口序列为目的的延伸程序,而后再调整参数进行扩增。In the amplification reaction step after fragmentation of the target sequence, an extension procedure with the purpose of completing the gap sequence is first performed, and then the parameters are adjusted for amplification.
  9. 根据权利要求1~4任一项所述的制备方法,其特征在于,所述转座酶识别序列包括转座酶的ME序列和连于转座酶的ME序列5’端的接头序列;The preparation method according to any one of claims 1 to 4, wherein the transposase recognition sequence includes the ME sequence of the transposase and a linker sequence connected to the 5' end of the ME sequence of the transposase;
    所述接头序列中碱基A的数量为1~20;The number of base A in the linker sequence is 1 to 20;
    所述接头序列包括TCGTCGGCAGCGTC、ACGATGTCAGCGAC、或AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC。The linker sequences include TCGTCGGCAGCGTC, ACGATGTCAGCGAC, or AAGAGACCACCAGAGTAGCAACGATGTCAGCGAC.
  10. 采用权利要求1~9任一项所述制备方法制备得到的随机探针。A random probe prepared using the preparation method described in any one of claims 1 to 9.
  11. 根据权利要求10所述的随机探针,其特征在于,所述随机探针的长度为100~500bps,所述随机探针中每100个核苷酸含有标记的数量为3~10个。The random probe according to claim 10, wherein the length of the random probe is 100-500 bps, and the number of labels contained in every 100 nucleotides in the random probe is 3-10.
  12. 权利要求10或11所述随机探针在核酸杂交测定中的应用。 The application of the random probe according to claim 10 or 11 in nucleic acid hybridization assay.
PCT/CN2023/091732 2022-05-09 2023-04-28 Random probe, preparation method therefor and use thereof WO2023216938A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202210495738.4 2022-05-09
CN202210495738 2022-05-09
CN202210531129.X 2022-05-16
CN202210531129.XA CN114891787B (en) 2022-05-09 2022-05-16 Random probe, preparation method and application

Publications (1)

Publication Number Publication Date
WO2023216938A1 true WO2023216938A1 (en) 2023-11-16

Family

ID=82723691

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/091732 WO2023216938A1 (en) 2022-05-09 2023-04-28 Random probe, preparation method therefor and use thereof

Country Status (2)

Country Link
CN (1) CN114891787B (en)
WO (1) WO2023216938A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114891787B (en) * 2022-05-09 2023-06-27 珠海圣美生物诊断技术有限公司 Random probe, preparation method and application
CN117343929B (en) * 2023-12-06 2024-04-05 广州迈景基因医学科技有限公司 PCR random primer and method for enhancing targeted enrichment by using same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128725A1 (en) * 1999-10-25 2007-06-07 Invitrogen Corporation Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination
US20100120098A1 (en) * 2008-10-24 2010-05-13 Epicentre Technologies Corporation Transposon end compositions and methods for modifying nucleic acids
CN105506035A (en) * 2016-02-05 2016-04-20 广州复能基因有限公司 Method for preparing RNA or DNA probe by taking multiple DNA fragments as formwork
US20180237950A1 (en) * 2015-02-25 2018-08-23 Jumpcode Genomics, Inc. Methods and compositions for in silico long read sequencing
CN109825498A (en) * 2019-03-15 2019-05-31 清华大学 For the preparation method of the probe of target nucleic acid target
CN114891787A (en) * 2022-05-09 2022-08-12 珠海圣美生物诊断技术有限公司 Random probe, preparation method and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230183780A1 (en) * 2016-07-25 2023-06-15 InVivo BioTech Services GmbH Dna probes for in situ hybridization on chromosomes
CN107603971B (en) * 2017-10-24 2020-02-04 厦门龙进生物科技有限公司 Preparation method of in-situ hybridization probe
CN110819696B (en) * 2018-08-14 2023-01-10 成都康弘生物科技有限公司 Preparation method and application of DNA probe
CN113724862B (en) * 2021-09-07 2023-11-07 广西爱生生命科技有限公司 Colorectal cancer biomarker and screening method and application thereof
CN114381496A (en) * 2021-12-30 2022-04-22 广州安必平医药科技股份有限公司 In-situ hybridization probe and preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128725A1 (en) * 1999-10-25 2007-06-07 Invitrogen Corporation Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination
US20100120098A1 (en) * 2008-10-24 2010-05-13 Epicentre Technologies Corporation Transposon end compositions and methods for modifying nucleic acids
US20180237950A1 (en) * 2015-02-25 2018-08-23 Jumpcode Genomics, Inc. Methods and compositions for in silico long read sequencing
CN105506035A (en) * 2016-02-05 2016-04-20 广州复能基因有限公司 Method for preparing RNA or DNA probe by taking multiple DNA fragments as formwork
CN109825498A (en) * 2019-03-15 2019-05-31 清华大学 For the preparation method of the probe of target nucleic acid target
CN114891787A (en) * 2022-05-09 2022-08-12 珠海圣美生物诊断技术有限公司 Random probe, preparation method and application

Also Published As

Publication number Publication date
CN114891787B (en) 2023-06-27
CN114891787A (en) 2022-08-12

Similar Documents

Publication Publication Date Title
WO2023216938A1 (en) Random probe, preparation method therefor and use thereof
CN106795514B (en) Bubble joint and application thereof in nucleic acid library construction and sequencing
CN1771335A (en) Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores
Maleki et al. A practical guide to studying G-quadruplex structures using single-molecule FRET
CN106460065A (en) Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications
CN112029903A (en) Primer group and kit for SARS-CoV-2 virus nucleic acid detection and application thereof
WO2023040723A1 (en) Sequencing linker, construction method, nanopore library construction kit and use
CN111534514A (en) Novel coronavirus detection kit based on Crisper
ES2646394T3 (en) Method to determine the repair function of incorrect DNA pairings
CN108913759A (en) A kind of fluorescence PCR primer, probe and detection method for target sequence detection
JP2008306935A (en) Method for quickly detecting nucleic acid
JP6153758B2 (en) Polymorph detection probe, polymorph detection method, drug efficacy determination method, and polymorph detection kit
US20220119882A1 (en) Single-stranded nucleic acid for real-time detection of genetic variation of single target gene and detection method using the same
CN110273004B (en) Reagent, method and kit for detecting gene methylation
CN109722471B (en) Method for improving uniformity of library rolling circle replication efficiency, library construction method and kit
CN112980844A (en) Detection kit for SARS-CoV-2 with transcription activity and use method
JP2017175953A (en) SYT-SSX fusion gene detection probe, SYT-SSX fusion gene detection probe set, SYT-SSX fusion gene detection method and SYT-SSX fusion gene detection kit
CN103667443B (en) Abrupt climatic change probe, mutation detection methods, method of evaluating drug effect and abrupt climatic change kit
CN111996271A (en) RPA detection primer group, kit and method for drug-resistant gene NDM-1 of superbacteria
CN112608913B (en) Gene expression regulation and control system based on C2C2 and application thereof
JPWO2006088165A1 (en) Gene detection reagent and use thereof
CN110511984A (en) The rapid fluorescence detection method and application of 19 exon deletion mutation of EGFR gene
CN110885887A (en) Artificial simulation nucleic acid molecular beacon and kit for detecting rs1517114 site polymorphism of C8orf34 gene
WO2023201487A1 (en) Adapter, adapter ligation reagent, kit, and library construction method
CN113186262B (en) Method and kit for rapid quantification of MGI platform high-throughput sequencing library

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23802710

Country of ref document: EP

Kind code of ref document: A1